Home
Mankind Pharma Ltd PE Ratio
![Image](/insights/_next/image?url=https%3A%2F%2Fstorage.googleapis.com%2Fassets.cdp.blinkx.in%2FBlinkx_Website%2Ficons%2Fmankind-pharma-ltd.png&w=128&q=75)
Mankind Pharma Ltd
NSE: MANKIND
PE
Key Highlights
- The P/E Ratio of Mankind Pharma Ltd is 48.9 as of 12 Feb 15:30 PM .
- The P/E Ratio of Mankind Pharma Ltd changed from 48.1 on March 2024 to 48.1 on March 2024 . This represents a CAGR of 0.00% over 1 years.
- The Latest Trading Price of Mankind Pharma Ltd is ₹ 2421 as of 12 Feb 15:30 .
- The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
- The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 36.9 in 2024.
Historical P/E Ratio of Mankind Pharma Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Mankind Pharma Ltd
Company Fundamentals for Mankind Pharma Ltd
![Image](/insights/_next/image?url=https%3A%2F%2Fstorage.googleapis.com%2Fassets.cdp.blinkx.in%2FBlinkx_Website%2Ficons%2Fmankind-pharma-ltd.png&w=128&q=75)
Mankind Pharma Ltd
NSE: MANKIND
Share Price
Market Price of Mankind Pharma Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
12 Feb 2025 | 2421.35 |
11 Feb 2025 | 2451.35 |
10 Feb 2025 | 2507.2 |
07 Feb 2025 | 2518.4 |
06 Feb 2025 | 2479.15 |
05 Feb 2025 | 2483.15 |
04 Feb 2025 | 2551.3 |
03 Feb 2025 | 2583.75 |
01 Feb 2025 | 2480.75 |
31 Jan 2025 | 2436.95 |
SWOT Analysis Of Mankind Pharma Ltd
BlinkX Score for Mankind Pharma Ltd
Asset Value vs Market Value of Mankind Pharma Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of P/E Ratio
Company | Market Cap | PE Ratio |
---|
Mankind Pharma Ltd | 99896 | 48.94 |
Sun Pharmaceuticals Industries Ltd | 406363 | 34.5 |
Divis Laboratories Ltd | 158396 | 76.6 |
Cipla Ltd | 117088 | 23.5 |
Torrent Pharmaceuticals Ltd | 103663 | 55.7 |
Dr Reddys Laboratories Ltd | 101458 | 18.9 |
Company | |
---|---|
Mankind Pharma Ltd | 99896 |
Sun Pharmaceuticals Industries Ltd | 406363 |
Divis Laboratories Ltd | 158396 |
Cipla Ltd | 117088 |
Torrent Pharmaceuticals Ltd | 103663 |
Dr Reddys Laboratories Ltd | 101458 |
PE Ratio of Mankind Pharma Ltd Explained
₹99896
Market cap
₹2041
Earnings
48.9X
PE Ratio
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.
P/E Ratio Formula
P/E ratio = (CMP of share/ Earning per share)
Types of Price to Earning Ratio
1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
PE Ratio of Pharmaceuticals Industry over time
PE Ratio of Top Sectors
Historical Market Cap of Mankind Pharma Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
Historical Market Cap of Mankind Pharma Ltd
Historical Revenue, EBITDA and Net Profit of Mankind Pharma Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Revenue, EBITDA and Net Profit of Mankind Pharma Ltd
Revenue
EBITDA
Net Profit
Historical Dividend Payout of Mankind Pharma Ltd
Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.
Historical Dividend Payout of Mankind Pharma Ltd
About Mankind Pharma Ltd
- Mankind Pharma Limited was incorporated on July 3, 1991, as a Private Limited Company with the name 'Mankind Pharma Private Limited', by the Registrar of Companies, Delhi and Haryana, at New Delhi.
- Pursuant to conversion of Company to a Public Limited dated July 14, 2005, name of the Company was changed to 'Mankind Pharma Limited' and the RoC issued a fresh Certificate of Incorporation on April 13, 2006. The Company is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations and chronic therapeutic areas across, as well as several consumer healthcare products.
- It is present in several acute and chronic therapeutic areas in India, including anti-infectives, cardiovascular, gastrointestinal, anti-diabetic, neuro/CNS, vitamins /minerals / nutrients and respiratory.
Mankind Pharma Ltd News Hub
Mankind Pharma allots 9000 equity shares under ESOP
Mankind Pharma has allotted 9000 equity shares under ESOP on 14 August 2024. Consequent to the afore
Read more
14 Aug 24
Mankind Pharma Ltd gains for fifth session
Mankind Pharma Ltd is up for a fifth straight session in a row. The stock is quoting at Rs 2150.3, u
Read more
12 Aug 24
Mankind Pharma Ltd soars 1.03%
Mankind Pharma Ltd is up for a third straight session in a row. The stock is quoting at Rs 2079.3, u
Read more
08 Aug 24
Mankind Pharma to transfer its OTC business to Mankind Consumer Products
Mankind Pharma has executed the Business Transfer Agreement (BTA) on 03 September 2024 to transfer O
Read more
03 Sept 24